人工尿道括约肌在中等程度前列腺切除术后压力性尿失禁中显著优于固定吊带:一项倾向评分匹配研究
该倾向评分匹配研究比较了人工尿道括约肌(AUS)与经闭孔尿道后吊带(RTS)治疗中等程度(每日3-5片尿垫)前列腺切除术后压力性尿失禁(PPI)的疗效。匹配后70例患者中,AUS组在12个月时达到主要结局的比例为94.3%,显著高于RTS组的68.6%(P<0.001),且客观漏尿量、ICIQ-SF评分及满意度均更优。
要点
- AUS在中等程度PPI患者中主观和客观疗效均显著优于RTS。
- AUS组12个月时0-1片/天尿垫率为94.3%,RTS组为68.6%(P=0.012)。
- 两组总体并发症和再干预率无显著差异,但Clavien-Dindo III级并发症仅见于AUS组。
核心结论
- 对于中等程度前列腺切除术后压力性尿失禁患者,AUS植入在主观和客观结局上均显著优于RTS。
研究设计与样本
- 倾向评分匹配研究,纳入2011年7月至2017年12月期间植入RTS或AUS且随访≥12个月的中等程度(每日3-5片尿垫)压力性为主PPI的连续男性患者,共109例,匹配后70例。
主要发现
- AUS组和RTS组分别有33例(94.3%)和24例(68.6%)达到主要结局(P<0.001)。
- 12个月时0-1片/天尿垫率分别为94.3%和68.6%(P=0.012),末次随访时为91.4%和68.6%(P=0.034)。
- 末次随访时,AUS组与RTS组的中位24小时漏尿量分别为0 mL和15 mL(P=0.017),中位ICIQ-SF评分分别为4和10(P=0.001),满意度分别为94.3%和68.6%(P=0.012)。
- 两组总体并发症率和再干预率无显著差异,但Clavien-Dindo III级并发症(n=3)仅发生于AUS组。
关键数值与推荐
- 主要结局定义为12个月时患者整体改善印象问卷至少「大幅改善」且未追加PPI手术或假体取出。
- 倾向评分匹配基于年龄、体重指数、Charlson合并症指数、尿垫使用量、既往放疗和尿道切开术。
临床怎么用
- 对于中等程度前列腺切除术后压力性尿失禁患者,AUS可作为优于RTS的治疗选择,但需注意AUS组中出现的Clavien-Dindo III级并发症。
局限性
- 本研究为回顾性倾向评分匹配分析,样本量有限(匹配后70例),随访时间中位数约4-5年,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the efficacy of artificial urinary sphincter (AUS) vs retrourethral transobturator sling (RTS) in men with moderate post-prostatectomy urinary incontinence (PPI) using propensity score-matching analysis to enhance the validity of the comparison (Canadian Task Force classification II-2). PATIENTS AND METHODS: Consecutive men with moderate (3-5 pads/day) stress-prevalent PPI were included if implanted with a RTS (TiLOOP® Male; pfm medical, Köln, Germany) or AUS (AMS800® ; Boston Scientific, Boston, MA, USA) since July 2011 to December 2017 and with ≥12 months of follow-up. Preoperative assessment included 24-h pad usage, International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), urethrocystoscopy, and urodynamics if indicated. Propensity score-matching analysis was based on age, body mass index, Charlson Comorbidity Index, pad usage, previous radiotherapy, and urethrotomy. The primary outcome was at least 'much improved' response at 12-months according to the Patient Global Impression of Improvement questionnaire, without additional PPI surgery or prosthesis explantation. RESULTS: Of 109 included patients, 70 patients were matched and the study groups were well balanced for the baseline matched variables. The median baseline 24-h pad usage was four in both groups (P = 0.10), and median follow-up was 51.2 months for AUS and 47.2 months (P = 0.5) for RTS patients. In the AUS and RTS cohorts, respectively, 33 (94.3%) and 24 (68.6%) patients achieved the primary outcome (P < 0.001), the 0-1 pad/day rates was 94.3% vs 68.6% (P = 0.012) at 12 months, and 91.4% vs 68.6% (P = 0.034) at last follow-up. At the last follow-up, the median 24-h leakage volumes, median ICIQ-SF scores and satisfaction rates were 0 vs 15 mL (P = 0.017), 4 vs 10 (P = 0.001), and 94.3% vs 68.6% (P = 0.012) in the AUS and RTS cohorts, respectively. There were no significant differences in overall rates of complications and re-interventions, although Clavien-Dindo Grade III complications (n = 3) occurred only in the AUS group. At sensitivity analysis, the study was reasonably robust to hidden bias. CONCLUSION: We found that AUS implantation significantly outperformed RTS in patients with moderate PPI for both subjective and objective outcomes.
引用
- Sacco E, Gandi C, Marino F, et al. Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study. BJU Int. 2020. PMID: 32744793. doi:10.1111/bju.15197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。